Ehizogie Edigin, MD: SLE Flare Hospitalizations Decreased Over 2 Decades

Video

In this interview, Dr. Edigin speaks about his longitudinal trend analysis that showed a decrease in SLE flare hospitalizations over the last 20 years.

Ehizogie Edigin, MD, Internal Medicine, John H Stroger Jr Hospital of Cook County, presented a study at the American College of Rheumatology 2021 Convergence. His study was titled, "Hospitalization for SLE Flare has Reduced over 2 Decades in the United States: A Longitudinal Population-based Study".

In this study, investigators found that the incidence of hospitalization for systemic lupus erythematosus (SLE) flare has decreased. However, when looking specifically at the African American population, systemic lupus erythematosus flare has increased.

Investigators noted that the reduction in hospitalizations could be due to the improvement of outpatient care and recognition of systemic lupus erythematosus flare.

Data were obtained for this study from the largest hospitalization database in the US, the National Inpatient Sample database (NIS). The longitudinal trend analysis was conducted over 21 years and looked at data from 1998-2018.

The incidence of SLE flare hospitalization reduced from 4.1 per 100,000 in 1998 down to 3.2 per 100,000 in 2018. However, in the African American population, SLE flare hospitalizations increased from 37.7% in 1998 to 44.7% in 2018.

Investigators said that racial trends between the SLE flare group and the control group were similar. While the results of the overall population showed a positive trend, additional research on the racial disparities are needed.

The motivation was to study longitudinal trends of SLE flare hospitalizations over the last 2 decades because longitudinal data are limited on SLE flare hospitalizations.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.